(Q37134430)

18 August 2017

1 reference

title

Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies (English)

1 reference

18 August 2017

1 reference

1 reference

2

Markus F Neurath

1 reference

18 August 2017

Imke Atreya

1

1 reference

18 August 2017

publication date

1 April 2008

1 reference

Expert Review of Anticancer Therapy

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

561-572

1 reference

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Metastatic colorectal cancer: current systemic treatment options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

The role of CD8(+) T cells in immune responses to colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Inflammatory cells and cancer: think different!

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Immunology and immunotherapy of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Colorectal cancer vaccines: principles, results, and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Inflammation and cancer: a double-edged sword.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Can aspirin prevent colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Cancer despite immunosurveillance: immunoselection and immunosubversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

From cancer immunosurveillance to cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Control of Effector CD8 + T Cell Function by the Transcription Factor Eomesodermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Follow-up of patients with curatively resected colorectal cancer: a practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Potent antitumor activity of interleukin-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Enhancing cancer vaccines with immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Use of cytokines in cancer vaccines/immunotherapy: recent developments improve survival rates for patients with metastatic malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

MHC class I antigens, immune surveillance, and tumor immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Natural killer cells, viruses and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Novel approaches using natural killer cells in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

The Cell Biology of Macrophage Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

EpCAM: A New Therapeutic Target for an Old Cancer Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17‐1A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Monoclonal antibody therapy for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Recombinant chimeric antibody hCAb as a novel anti-human colorectal carcinoma agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Chemokines: key players in innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Dendritic cell-based cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Cytokines and their effects on maturation, differentiation and migration of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

Cancer incidence and mortality in Europe, 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.4.561

21 January 2018

Identifiers

DOI

10.1586/14737140.8.4.561

1 reference

18 August 2017

1 reference